Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis
Stock Information for Ardelyx Inc.
Loading
Please wait while we load your information from QuoteMedia.